ADTRAN Inc. (NASDAQ:ADTN) belongs to Technology sector. Its net profit margin is 6.10% and weekly performance is 7.87%. On last trading day company shares ended up $17.28. ADTRAN Inc. (NASDAQ:ADTN) distance from 50-day simple moving average (SMA50) is 3.57%. Networking and communications equipment provider ADTRAN Inc. (NASDAQ:ADTN) announced that its Board has authorized the repurchase of an additional 5 million shares of the Company’s common stock to commence upon completion of the repurchase plan announced May 19, 2014. There are 1.87 million shares remaining to be repurchased under the May 2014 plan.
Richmont Mines Inc. (NYSEMKT:RIC) shares advanced 4.56% in last trading session and ended the day at $3.21. RIC Gross Margin is 19.50% and its return on assets is 8.30%. Richmont Mines Inc. (NYSEMKT:RIC) quarterly performance is 7.00%. Richmont Mines Inc. (NYSEMKT:RIC) announce plans to proceed with the development of the deeper Q Zone at the Beaufor Mine in Quebec. The positive decision is based on a comprehensive analysis of both geological and economic factors, and is expected to extend the mine’s life by a minimum of two years with an annual estimated production rate of 20,000 to 25,000 ounces in 2016 and 2017.
On 14 July, Celgene Corporation (NASDAQ:CELG) shares advanced 1.62% and was closed at $122.85. CELG EPS growth in last 5 year was 23.60%. Celgene Corporation (NASDAQ:CELG) year to date (YTD) performance is 9.82%. Cancer-drug company Celgene Corporation (NASDAQ:CELG) on Tuesday said it will pay $7.2 billion for Receptos Inc. in a bid to move deeper into the multibillion-dollar market for autoimmune diseases. Under the terms, Celgene will pay $232 a share for Receptos, a 12% premium to Tuesday’s closing price. Receptos stock, which traded at $107.22 a share in late January, had risen in recent months amid takeover speculation.
GlaxoSmithKline plc (NYSE:GSK) ended the last trading day at $43.34. Company weekly volatility is calculated as 1.03% and price to cash ratio as 6.41. GlaxoSmithKline plc (NYSE:GSK) showed a weekly performance of 3.66%. HIV drugs are proving to be so effective in containing the virus that GlaxoSmithKline plc (NYSE:GSK) foresees a time, a decade away, when its most profitable business unit may no longer have a purpose.
Cabela’s Incorporated (NYSE:CAB) shares fell -0.77% in last trading session and ended the day at $51.58. CAB Gross Margin is 43.50% and its return on assets is 2.80%. Cabela’s Incorporated (NYSE:CAB) quarterly performance is -5.84%. Cabela’s Incorporated (NYSE:CAB) announced it is scheduled to release second quarter 2015 financial results before the market opens on Thursday, July 23, 2015.